Evidence map›Paper›PMID 33094146›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2020

CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus.

Manuel Montero-Odasso, Frederico Pieruccini-Faria, Zahinoor Ismail, Karen Li, Andrew Lim, Natalie Phillips, Nellie Kamkar, Yanina Sarquis-Adamson, Mark Speechley, Olga Theou and 3 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. [Early Alzheimer's disease recognition via multimodal hand movement quality assessment].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  18. Postural Control Characteristics in Alzheimer's Disease, Dementia With Lewy Bodies, and Vascular Dementia.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  19. Impact of Mild Behavioral Impairment on Longitudinal Changes in Cognition.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Manuel Montero-OdassoGait and Brain Laboratory Parkwood Institute Lawson Health Research Institute London Ontario Canada.
Frederico Pieruccini-FariaGait and Brain Laboratory Parkwood Institute Lawson Health Research Institute London Ontario Canada.
Zahinoor IsmailDepartments of Psychiatry Clinical Neurosciences and Community Health Sciences Hotchkiss Brain Institute and O'Brien Institute for Public Health University of Calgary Calgary Alberta Canada.
Karen LiCentre for Research in Human Development Concordia University Montreal Quebec Canada.
Andrew LimDivision of Neurology Department of Medicine Sunnybrook Health Sciences Centre Toronto Ontario Canada.
Natalie PhillipsCentre for Research in Human Development Concordia University Montreal Quebec Canada.
Nellie KamkarGait and Brain Laboratory Parkwood Institute Lawson Health Research Institute London Ontario Canada.
Yanina Sarquis-AdamsonGait and Brain Laboratory Parkwood Institute Lawson Health Research Institute London Ontario Canada.
Mark SpeechleyDepartment of Epidemiology and Biostatistics University of Western Ontario London Ontario Canada.
Olga TheouSchool of Physiotherapy Dalhousie University Halifax Nova Scotia Canada.
Joe VergheseDepartment of Neurology Albert Einstein College of Medicine Bronx New York USA.
Lindsay WallaceDepartment of Medicine Dalhousie University Halifax Nova Scotia Canada.
Richard CamicioliDivision of Neurology Department of Medicine University of Alberta Edmonton Alberta Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCognitive impairment is the hallmark of Alzheimer's disease (AD) and related dementias. However, motor decline has been recently described as a prodromal state that can help to detect at-risk individuals. Similarly, sensory changes, sleep and behavior disturbances, and frailty have been associated with higher risk of developing dementia. These clinical findings, together with the recognition that AD pathology precedes the diagnosis by many years, raises the possibility that non-cognitive changes may be early and non-invasive markers for AD or, even more provocatively, that treating non-cognitive aspects may help to prevent or treat AD and related dementias.

methodsA subcommittee of the Canadian Consensus Conference on Diagnosis and Treatment of Dementia reviewed areas of emerging evidence for non-cognitive markers of dementia. We examined the literature for five non-cognitive domains associated with future dementia: motor, sensory (hearing, vision, olfaction), neuro-behavioral, frailty, and sleep. The Grading of Recommendations Assessment, Development, and Evaluation system was used to assign the strength of the evidence and quality of the recommendations. We provide recommendations to primary care clinics and to specialized memory clinics, answering the following main questions: (1) What are the non-cognitive and functional changes associated with risk of developing dementia? and (2) What is the evidence that sensory, motor, behavioral, sleep, and frailty markers can serve as potential predictors of dementia?

resultsEvidence supported that gait speed, dual-task gait speed, grip strength, frailty, neuropsychiatric symptoms, sleep measures, and hearing loss are predictors of dementia. There was insufficient evidence for recommending assessing olfactory and vision impairments as a predictor of dementia.

conclusionsNon-cognitive markers can assist in identifying people at risk for cognitive decline or dementia. These non-cognitive markers may represent prodromal symptoms and several of them are potentially amenable to treatment that might delay the onset of cognitive decline.

Indexed as

behaviorbiomarkercognitive impairmentdementiafrailtygaithearingolfactionparkinsonismpredictionrisksleepvision

Identifiers

PMID33094146
PMCPMC7568425

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.